Net Cash Provided by (Used in) Operating Activities |
89.3K |
USD |
|
Q3 2024 |
Q1 2025 |
Net Cash Provided by (Used in) Financing Activities |
192K |
USD |
|
Q3 2024 |
Q1 2025 |
Net Cash Provided by (Used in) Investing Activities |
0 |
USD |
|
Q3 2024 |
Q1 2025 |
Common Stock, Shares Authorized |
5B |
shares |
0% |
Q4 2024 |
Q2 2025 |
Common Stock, Shares, Issued |
2.1B |
shares |
0% |
Q4 2024 |
Q2 2025 |
Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q4 2024 |
Q2 2025 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
281K |
USD |
+25545% |
Q3 2024 |
Q1 2025 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
150K |
USD |
+7044% |
Q4 2024 |
Q2 2025 |
Deferred Tax Assets, Valuation Allowance |
0 |
USD |
-100% |
Q2 2024 |
FY 2024 |
Comprehensive Income (Loss), Net of Tax, Attributable to Parent |
1.25M |
USD |
-43% |
Q4 2024 |
Q2 2025 |
Preferred Stock, Shares Issued |
0 |
shares |
|
Q4 2024 |
Q2 2025 |
Preferred Stock, Shares Authorized |
20M |
shares |
0% |
Q4 2024 |
Q2 2025 |
Additional Paid in Capital |
-3.64M |
USD |
-450% |
Q4 2024 |
Q2 2025 |
Preferred Stock, Shares Outstanding |
0 |
shares |
|
Q4 2024 |
Q2 2025 |
Deferred Tax Assets, Net of Valuation Allowance |
0 |
USD |
-100% |
Q2 2024 |
FY 2024 |
Preferred Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q4 2024 |
Q2 2025 |